We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email :PharmaSources@imsinoexpo.com
Whatsapp :+86-13621645194
Main Sales Markets: North America,Western Europe,Eastern Europe,Asia,Middle East,Africa
Monthly Production Capacity: 600,000 vials
Delivery Lead Time: 2 months
Sample Provided: no
Payment Terms: T/T
Levocarnitine for Injection
NMPA Approval
Note: the content below do not include all the information needed to use Levocarnitine for Injection safely and effectively. Please read the package insert carefully and follow the doctors’ instructions before use the product.
INDICATIONS AND USAGE
It is indicated for chronic renal failure patients with long-term hemodialysis who have a series of concurrent symptoms due to secondary carnitine deficiency, such as cardiomyopathy, skeletal myopathy, arrhythmia, hyperlipidemia, hypotension and muscle spasm during dialysis.
DOSAGE AND ADMINISTRATION
After each hemodialysis, the recommended starting dose is 10-20mg / kg. After dissolved in 5~10 ml of water for injection, the drug is injected intravenously once every 2~3 minutes. Once the concentration of plasma level of L-carnitine trough is lower than normal range (40-50umol / L), the treatment should be started immediately, and the dose should be adjusted at the third or fourth week of treatment (such as 5mg / kg after hemodialysis).